Public Scientific Research & Academic Publishing
The visible scientific breakthroughs (AlphaFold database, research papers) made available to the public and research communities.
Source: Internal Alphabet Research Cost SegmentsB2B Enterprise Model API & Pharma IP Licensing
The commercial milestone contracts from drug discovery deals (Isomorphic Labs) and Google Cloud Vertex AI commercial APIs.
Source: Isomorphic Labs Strategic Press Releases & Vertex AI API ProjectionsThe real wealth is in what is NOT SEEN—how they leverage their breakthroughs to protect Google's high-margin advertising monopoly through custom TPU-optimized search routing (Services - Digital) and package their computational model IP to sign multi-billion-dollar drug discovery partnerships with global pharmaceutical giants like Eli Lilly and Novartis (Brand - Digital).
But which money gates does Google DeepMind use to stack this cashflow? Click each ? to reveal how they use that gate.
| AGENT // PROFIT OPENER | THE SEEN (PHYSICAL/DIGITAL) | THE UNSEEN (PHYSICAL/DIGITAL) |
|---|---|---|
| 1. Products | — | — |
| 2. Services | — | |
| 3. Access | — | |
| 4. Attention | — | — |
| 5. Money | — | — |
| 6. Risk | — | — |
| 7. Brand | — | |
Strategic Translation
The underlying economic infrastructure driving this profit extraction design.
What is the explicit promise the customer buys?
High-profile research publications, game-playing accomplishments (AlphaGo), and the free public AlphaFold protein structure database.
What asset is quietly accumulating as a result?
Elite AI research talent, pre-trained proprietary models (Gemini, AlphaFold), and Alphabet's custom TPU (Tensor Processing Unit) computing clusters.